Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.China |
First Approval Date22 Nov 2004 |
100 Clinical Results associated with Guizhou Yinxingying Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Guizhou Yinxingying Pharmaceutical Co., Ltd.
100 Deals associated with Guizhou Yinxingying Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Guizhou Yinxingying Pharmaceutical Co., Ltd.